Table 1.
Participants’ characteristics
| Variable | n (%) |
|---|---|
| Age, years (mean ± SD) | 57.47 ± 13.20 |
| Gender | |
| Male | 992 (47.81) |
| Female | 1083 (52.19) |
| Primary cancer | |
| Head and neck | 309 (14.89) |
| Gastrointestinal and colon-rectum | 394 (18.99) |
| Hepatobiliary and pancreas | 120 (5.78) |
| Breast | 527(25.40) |
| Lung and mediastinum | 184 (8.87) |
| Blood/lymphoma | 314 (15.18) |
| Gynecological and genitourinary | 133 (6.41) |
| Others | 93 (4.48) |
| Disease status | |
| Disease free | 407 (19.61) |
| Relief | 1226 (59.08) |
| Deterioration | 442 (21.30) |
| Pain caused by cancer | |
| Yes | 906 (43.66) |
| No | 564 (27.18) |
| Undetermined | 605 (29.16) |
| Pain caused by anti-cancer therapy | |
| Yes | 285 (13.73) |
| No | 1790 (86.27) |
SD, standard deviation.